Grünenthal’s response to

Covid-19, the new coronavirus

Grünenthal considers the outbreak and spread of Covid-19 (known as new coronavirus) to be a serious situation and fully recognises its responsibilities related to safeguarding the well-being and safety of our employees.

... View Statement

Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain.​


We are present in 29 countries with affiliates in Europe, Latin America and the US.

Market presence

Our products are sold in more than 100 countries.


4,700 employees work for our group worldwide.

What we do

As a fully integrated research & development company we bring innovative pain treatments and state-of-the-art technologies to patients.

... Learn more about us

Pioneering thinkers

Our passion is innovation. We are driven to seek new solutions for patients with severe diseases and high unmet medical needs – and make these solutions accessible to patients.
... Find out more


Ready to create a brighter future for our patients? With us, let your passion and ideas flow and drive innovation to improve our patients’ lives.

Join forces.

Make an impact.

Innovate for a world free of pain.

... Work with Grünenthal

External Link:

You are now leaving the Grünenthal (UK) website. You will be re-directed to an external website. Grünenthal UK Ltd. accepts no responsibility for the content of other websites.

... Cancel ... Ok